dc.contributor.author | Linhardt, Robert J. | |
dc.contributor.author | Liu, J. | |
dc.date | 2012 | |
dc.date.accessioned | 2022-06-23T04:14:46Z | |
dc.date.available | 2022-06-23T04:14:46Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Synthetic heparin, R. J. Linhardt, J. Liu, Current Opinion in Pharmacology, 12, 217–219, 2012. | |
dc.identifier.uri | https://hdl.handle.net/20.500.13015/5313 | |
dc.identifier.uri | https://doi.org/10.1016/j.coph.2011.12.002 | |
dc.description | Current Opinion in Pharmacology, 12, 217–219 | |
dc.description | Note : if this item contains full text it may be a preprint, author manuscript, or a Gold OA copy that permits redistribution with a license such as CC BY. The final version is available through the publisher’s platform. | |
dc.description.abstract | Heparin is a complex polysaccharide-based anticoagulant drug that is essential for the practice of modern medicine. Used in extracorporeal therapies, such as kidney dialysis, in the treatment of coagulation disorders, such as deep vein thrombosis (DVT), and to passivate the surfaces of indwelling devices, such as catheters, a heparin-based product is the first choice whenever blood clotting needs to be prevented or controlled. | |
dc.language | en_US | |
dc.language.iso | ENG | |
dc.publisher | Elsevier | |
dc.relation.ispartof | The Linhardt Research Labs Online Collection | |
dc.relation.ispartof | Rensselaer Polytechnic Institute, Troy, NY | |
dc.relation.uri | https://harc.rpi.edu/ | |
dc.subject | Biology | |
dc.subject | Chemistry and chemical biology | |
dc.subject | Chemical and biological engineering | |
dc.subject | Biomedical engineering | |
dc.title | Synthetic heparin | |
dc.type | Article | |
dcterms.accessRights | A full text version is available in DSpace@RPI | |
dcterms.isVersionOf | https://doi.org/10.1016/j.coph.2011.12.002 | |
dc.rights.holder | In Copyright : this Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). https://rightsstatements.org/page/InC/1.0/ | |
dc.creator.identifier | https://orcid.org/0000-0003-2219-5833 | |
dc.relation.department | The Linhardt Research Labs. | |
dc.relation.department | The Shirley Ann Jackson, Ph.D. Center for Biotechnology and Interdisciplinary Studies (CBIS) | |